Elevated concentrations of C-reactive protein in subjects with Type 2 diabetes mellitus are moderately influenced by glycemic control

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Endocrinological Investigation

• Publication date

  2003-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF03345160PMID 12809171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm

  2002cited by this paper
• The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study.

  2001cited by this paper
• Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetes.

  2001cited by this paper
• Elevated C-Reactive Protein: Another Component of the Atherothrombotic Profile of Abdominal Obesity

  2001cited by this paper
• Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes.

  2000cited by this paper
• Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

  2000cited by this paper
• C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

  2000cited by this paper
• Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population.

  2000cited by this paper
• The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II Diabetic subjects

  2000cited by this paper
• The New England Journal

  2000cited by this paper
• Increased levels of C-reactive protein in noncontrolled type II diabetic subjects.

  1999cited by this paper
• C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.

  1999cited by this paper
• C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

  1999cited by this paper
• Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women.

  1999cited by this paper
• Body mass index, diabetes, and C-reactive protein among U.S. adults.

  1999cited by this paper
• Is Type II diabetes mellitus a disease of the innate immune system?

  1998cited by this paper
• Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research.

  1997cited by this paper
• Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects.

  1997cited by this paper
• NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

  1997cited by this paper
• Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications.

  1997cited by this paper
• Oxford Textbook of Medicine

  1997cited by this paper
• Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial.

  1996cited by this paper
• Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.

  1995cited by this paper
• Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors

  1995cited by this paper
• The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results.

  1995cited by this paper
• Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumour necrosis factor-alpha.

  1992cited by this paper
• The Cardiovascular Health Study: design and rationale.

  1991cited by this paper
• Albuminuria reflects widespread vascular damage

  1989cited by this paper
• Increased levels of acute-phase serum proteins in diabetes.

  1989cited by this paper
• Atherosclerosis and lipoproteins.

  1955cited by this paper

• Pharmacokinetics in pregnancy

  2022cites this paper
• Glycaemic control and C- reactive protein levels in type 2 diabetes mellitus -how well they co-relate?: a prospective study

  2019cites this paper
• DIABETES MELLITUS AND MECHANISM OF CHRONIC COMPLICATIONS: REVIEW ARTICLE

  2017cites this paper
• Chapter 3 – Pharmacokinetics in Pregnancy

  2017cites this paper
• Serum High Sensitive - C Reactive Protein Levels in Type 2 Diabetes Mellitus -A Case Control Study

  2016cites this paper
• Mildly elevated serum total bilirubin levels are negatively associated with carotid atherosclerosis among elderly persons with type 2 diabetes

  2016cites this paper
• CRP, AN INFLAMMATORY BIOMARKER IN TYPE 2 DIABETES MELLITUS

  2015cites this paper
• STUDY OF ENDOGENOUS SEX HORMONES AND INFLAMMATION IN ELDERLY WOMEN WITH DIABETES MELLITUS

  2014cites this paper
• Impact of Diabetes on Drug Disposition Mechanisms in Pregnancy

  2012influential citation
• Association of hs-CRP with Diabetic and Non-diabetic individuals

  2010cites this paper
• Inflammation and its echo in atherosclerosis

  2009cites this paper
• Procédés pour améliorer la fonction des cellules bêta

  2009cites this paper
• Independent anti‐inflammatory effect of insulin in newly diagnosed type 2 diabetes

  2009cites this paper
• Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein.

  2008cites this paper
• Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus.

  2007cites this paper
• Effects of α-Tocopherol and Mixed Tocopherol Supplementation on Markers of Oxidative Stress and Inflammation in Type 2 Diabetes

  2007cites this paper
• Effects of alpha-tocopherol and mixed tocopherol supplementation on markers of oxidative stress and inflammation in type 2 diabetes.

  2007cites this paper
• A single bolus infusion of C-reactive protein increases gluconeogenesis and plasma glucose concentration in humans.

  2007cites this paper
• C-reactive protein genotype affects exercise training-induced changes in insulin sensitivity.

  2006cites this paper
• Vitamin E and atherosclerosis: investigation of novel biological activities and metabolism of gamma-tocopherol in humans

  2006cites this paper
• Metformin reduces C–reactive protein but not complement factor C3 in overweight patients with Type 2 diabetes mellitus

  2005cites this paper
• Association of C‐reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: The Chennai Urban Rural Epidemiology Study (CURES‐6)

  2005cites this paper
• New insights on oxidative stress in the artery wall

  2005cites this paper
• Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease?

  2005cites this paper
• The relationship between levels of alpha1-acid glycoprotein and metabolic parameters of diabetes mellitus.

  2004cites this paper
• Role of oxidative modifications in atherosclerosis.

  2004cites this paper
• Association between acute-phase reactants and advanced glycation end products in type 2 diabetes.

  2004cites this paper